Fortive/$FTV
1D1W1MYTD1Y5YMAX
Capital at risk
About Fortive
Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
- Ticker
- $FTV
- Sector
- Industrials
- Primary listing
- NYSE
- Employees
- 10,000
- Headquarters
- Everett, United States
- Website
- www.fortive.com
Fortive Metrics
BasicAdvanced
$17B
33.15
$1.68
0.98
$0.25
0.50%
Price and volume
Market cap
$17B
Beta
0.98
52-week high
$64.56
52-week low
$47.71
Average daily volume
2.2M
Dividend rate
$0.25
Financial strength
Current ratio
1.241
Quick ratio
0.802
Long term debt to equity
0.593
Total debt to equity
0.593
Dividend payout ratio (TTM)
10.55%
Interest coverage (TTM)
6.38%
Profitability
EBITDA (TTM)
1,234.6
Gross margin (TTM)
63.23%
Net profit margin (TTM)
12.38%
Operating margin (TTM)
18.24%
Effective tax rate (TTM)
10.39%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
3.30%
Return on equity (TTM)
7.32%
Valuation
Price to earnings (TTM)
33.15
Price to revenue (TTM)
4.08
Price to book
2.79
Price to tangible book (TTM)
-5.12
Price to free cash flow (TTM)
18.778
Free cash flow yield (TTM)
5.33%
Free cash flow per share (TTM)
2.974
Dividend yield (TTM)
0.45%
Forward dividend yield
0.50%
Growth
Revenue change (TTM)
5.62%
Earnings per share change (TTM)
-24.02%
3-year revenue growth (CAGR)
-10.27%
10-year revenue growth (CAGR)
-3.45%
3-year earnings per share growth (CAGR)
-9.03%
10-year earnings per share growth (CAGR)
-3.76%
3-year dividend per share growth (CAGR)
-24.61%
What the Analysts think about Fortive
Analyst ratings (Buy, Hold, Sell) for Fortive stock.
Analyst projections of the future price of Fortive stock.
Bulls say / Bears say
Fortive’s Q2 performance showed broad-based momentum: core revenue rose 6.7%, adjusted EBITDA increased 12% and adjusted EPS grew 28%. Management raised 2026 adjusted EPS guidance to $2.95–$3.05 and lifted expected core growth to about 4%. (Financial Times, Fortive)
Fortive is adding higher-value recurring revenue to its industrial franchises. Fluke is attaching services and software to instruments, while AI-enabled tools at eMaint, ServiceChannel and Gordian are gaining customer adoption; healthcare consumables and services provide another recurring stream. (StockAnalysis, StockAnalysis)
Strong cash generation gives Fortive room to invest and return capital. Trailing-twelve-month free cash flow was $1.04 billion in Q2, while buybacks had retired about 11% of shares since the new Fortive launch and the dividend was raised by more than 16%. (Financial Times, EarningsCalls.dev)
The shares appear priced for continued execution rather than a large margin of safety. Fortive traded at roughly 35–36 times earnings in August, while the analyst consensus was Hold, leaving scope for valuation compression if growth or margins disappoint. (Daily Political, Investing.com)
Near-term earnings delivery is uneven. Management expects third-quarter EBITDA margins to be slightly below Q2 levels, and four fewer selling days in Q4 are expected to cut revenue by $15–$20 million and reduce Q4 core growth by about 150 basis points. (The Motley Fool, EarningsCalls.dev)
Fortive still carries meaningful financial and operating risk after refinancing: Q2 filings showed $3.51 billion of long-term debt and $1.08 billion of commercial paper, with full-year net interest expense expected at about $140 million. Tariffs, uneven healthcare spending and weaker international demand could make that leverage harder to absorb. (StockTitan, Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 24 Sept 2026.
Fortive Financial Performance
Revenues and expenses
Fortive Earnings Performance
Company profitability
Upcoming events
No upcoming events
Fortive News
AllArticlesVideos
Funds containing Fortive
AllUSDEURGBP
Fund name | Fund size | $FTV weighting |
|---|---|---|
iShares Automation & Robotics$RBOT | $5.2B | 0.87% |
iShares Automation & Robotics€2B76 | €4.5B | 0.87% |
iShares Automation & Robotics£RBTX | £3.8B | 0.87% |
iShares S&P 500 Industrials Sector€2B7C | €673M | 0.31% |
iShares S&P 500 Industrials Sector£IISU | £578M | 0.31% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.